ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

ARCT Arcturus Therapeutics Holdings Inc

26.63
0.00 (0.00%)
Pre Mercado
Última actualización: 06:00:02
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Arcturus Therapeutics Holdings Inc ARCT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 26.63 06:00:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
26.63
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202415:01BWArcturus Therapeutics to Report First Quarter Financial..
07/3/202415:05EDGAR2Form 8-K - Current report
07/3/202415:01BWArcturus Therapeutics Announces Fourth Quarter and Fiscal..
26/2/202408:00BWArcturus Therapeutics to Present at the Barclays 26th Annual..
23/2/202415:05EDGAR2Form 8-K - Current report
22/2/202407:30BWArcturus Therapeutics Receives Orphan Medicinal Product..
20/2/202408:00BWArcturus Therapeutics to Report Fourth Quarter and Full Year..
05/2/202407:30PRNUSNew COVID-19 sa-mRNA Results from CSL and Arcturus..
21/12/202307:00PRNUSCSL and Arcturus Therapeutics' ARCT-154 Demonstrates..
19/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202307:30BWArcturus Therapeutics to Present at the 42nd Annual J.P...
28/11/202307:05PRNUSJapan's Ministry of Health, Labour and Welfare Approves CSL..
28/11/202307:00BWJapan's Ministry of Health, Labour and Welfare Approves CSL..
27/11/202308:13DJNArcturus Therapeutics Gets FDA Orphan Designation for..
27/11/202307:30BWArcturus Therapeutics Receives Orphan Drug Designation from..
15/11/202307:51IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
14/11/202315:10EDGAR2Form 8-K - Current report
14/11/202315:01BWArcturus Therapeutics Announces Third Quarter 2023 Financial..
25/10/202315:01BWArcturus Therapeutics to Report Third Quarter Financial..
23/10/202315:01BWArcturus Therapeutics to Attend Upcoming Investor &..
04/10/202307:30BWArcturus Therapeutics Joint Venture mRNA Manufacturing..
26/9/202315:06EDGAR2Form 8-K - Current report
26/9/202307:30BWArcturus Therapeutics and Cystic Fibrosis Foundation Extend..
19/9/202307:30BWStudy Shows Novel sa-mRNA Vaccines Offer Robust, Broad,..
05/9/202307:30BWArcturus Therapeutics and CSL Announce European Medicines..
17/8/202307:30BWArcturus Therapeutics to Attend Upcoming Investor..
14/8/202308:00BWArcturus Therapeutics Joint Venture mRNA Manufacturing..
07/8/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202315:23EDGAR2Form 8-K - Current report
07/8/202315:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/8/202315:01BWArcturus Therapeutics Announces Second Quarter 2023..
03/8/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202315:01BWArcturus Therapeutics to Report Second Quarter 2023..
14/7/202306:53EDGAR2Form 8-K - Current report
30/6/202307:28EDGAR2Form 8-K - Current report
01/6/202307:30BWArcturus Therapeutics Receives U.S. FDA Fast Track..
09/5/202315:01BWArcturus Therapeutics Announces First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock